Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A tick-borne, infectious disease caused by Anaplasma phagocytophilum, an obligate intracellular bacterium that is typically transmitted to humans by ticks of the Ixodes ricinus species complex.
Biomarker and diagnostic research for human granulocytic anaplasmosis has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
205 publications have been identified in PubMed for human granulocytic anaplasmosis. Kisho has analyzed 128 by research type. Research spans Review / Meta-Analysis (42%), Epidemiology / Natural History (23%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 54 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:02 AM UTC
Genetic and Rare Diseases Info Center
Disease patterns and progression | 29 | 23% |
Laboratory research | 27 | 21% |
Patient case studies | 14 | 11% |
Testing and diagnosis research | 3 | 2% |
Other research | 1 | 1% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Katragadda S (2026). [PMID: 40176262](https://pubmed.ncbi.nlm.nih.gov/40176262/). *Clin Infect Dis*. [Review / Meta-Analysis]
Huang Y (2026). [PMID: 41544799](https://pubmed.ncbi.nlm.nih.gov/41544799/). *Metabolism*. [Epidemiology / Natural History]
Denton SL (2026). [PMID: 41867746](https://pubmed.ncbi.nlm.nih.gov/41867746/). *bioRxiv*. [Basic Science / Preclinical]
Biernacki M (2026). [PMID: 41764219](https://pubmed.ncbi.nlm.nih.gov/41764219/). *Sci Rep*. [Epidemiology / Natural History]
Amarapathy S (2026). [PMID: 41986011](https://pubmed.ncbi.nlm.nih.gov/41986011/). *Prog Mol Biol Transl Sci*. [Review / Meta-Analysis]
Lind MCH (2026). [PMID: 41733347](https://pubmed.ncbi.nlm.nih.gov/41733347/). *mBio*. [Basic Science / Preclinical]
Dobrzyńska M (2026). [PMID: 41679049](https://pubmed.ncbi.nlm.nih.gov/41679049/). *Biomed Pharmacother*. [Diagnostic / Biomarker]
Pichon E (2026). [PMID: 41025404](https://pubmed.ncbi.nlm.nih.gov/41025404/). *Mov Disord Clin Pract*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Epidemiology / Natural History]